OMass Therapeutics
OMass Therapeutics is developing small molecule drugs to treat diseases and immunological conditions.
Oxford, UKwww.omass.com ↗
Total raised
€90M
€89,612,967
Funding rounds
1
Investors
6
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood35
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-28 | Series B | €90M | GV,Northpond Ventures,Oxford Science Enterprises,Oxford University Innovation Fund,Sanofi Ventures,Syncona Partners | View deal → |
Investors
6Related news
- Oxford spinout raises £75m to find medicines for rare diseasesbusinesscloud.co.uk · 2022-04